Cargando…
Institutional Incidence of Severe tPA-Induced Angioedema in Ischemic Cerebral Vascular Accidents
INTRODUCTION: Tissue plasminogen activator (tPA) is commonly used in ischemic cerebral vascular accidents (CVAs). tPA is generally well tolerated; however, orolingual angioedema is a well-documented adverse effect. Angioedema is generally mild, transient, and unilateral but can manifest as severe, l...
Autores principales: | Sczepanski, Matthew, Bozyk, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180929/ https://www.ncbi.nlm.nih.gov/pubmed/30363665 http://dx.doi.org/10.1155/2018/9360918 |
Ejemplares similares
-
Hemi Orolingual Angioedema after tPA Administration for Acute Ischemic Stroke
por: Madden, Bryan, et al.
Publicado: (2015) -
Angioedema Secondary to tPA Use in Acute Ischemic Stroke Patient with Hypertension: A Case Report
por: Kim, Chris, et al.
Publicado: (2021) -
To tPA or Not to tPA: Two Medical-Legal Misadventures of Diagnosing a Cerebrovascular Accident as a Stroke Mimic
por: Moore, Malia J., et al.
Publicado: (2019) -
tPA or not tPA? Lysis therapy in the setting of COVID‐19 and ECMO
por: Cromartie, Anjelica, et al.
Publicado: (2022) -
Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19
por: Carneiro, Thiago, et al.
Publicado: (2020)